HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of perioperative bleeding on the protective effect of β-blockers during infrarenal aortic reconstruction.

AbstractBACKGROUND:
The use of β-blockers during the perioperative period remains controversial. Although some studies have demonstrated their protective effects regarding postoperative cardiac complications, others have demonstrated increased mortality when β-blockers were introduced before surgery.
METHODS:
In this observational study involving 1,801 patients undergoing aortic reconstruction, we prospectively assessed β-blocker therapy compared with no β-blocker therapy, with regard to cardiac and noncardiac postoperative outcomes using a propensity score approach. The impact of β-blockers was analyzed according to the intraoperative bleeding estimated by transfusion requirements.
RESULTS:
In-hospital mortality was 2.5% (n=45), β-blocker use was associated with a reduced frequency of postoperative myocardial infarction (OR=0.46, 95% CI [0.26; 0.80]) and myocardial necrosis (OR=0.62, 95% CI [0.43; 0.88]) in all patients, but also with an increased frequency of multiple organ dysfunction syndromes (OR=2.78, 95% CI [1.71; 4.61]). In patients with severe bleeding (n=163; 9.1%), the frequency of in-hospital death (OR=6.65, 95% CI [1.09; 129]) and/or multiple organ dysfunction syndromes (OR=4.18, 95% CI [1.81; 10.38]) were markedly increased. Furthermore, no more than 28% of the patients who died presented with postoperative myocardial infarction, whereas 69% of the patient with a postoperative myocardial infarction also presented an excessive bleeding.
CONCLUSIONS:
Perioperative β-blocker therapy was associated with an overall reduction in postoperative cardiac events. In the vast majority of patients with low perioperative bleeding, the global effect of β-blockers was protective; in contrast, patients given β-blockers who experienced severe bleeding had higher mortality and an increased frequency of multiorgan dysfunction syndrome.
AuthorsYannick Le Manach, Gary S Collins, Cristina Ibanez, Jean Pierre Goarin, Pierre Coriat, Julien Gaudric, Bruno Riou, Paul Landais
JournalAnesthesiology (Anesthesiology) Vol. 117 Issue 6 Pg. 1203-11 (Dec 2012) ISSN: 1528-1175 [Electronic] United States
PMID22652895 (Publication Type: Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
Topics
  • Acute Kidney Injury (mortality, prevention & control)
  • Adrenergic beta-Antagonists (therapeutic use)
  • Aged
  • Aorta, Abdominal (pathology, surgery)
  • Blood Loss, Surgical (mortality, prevention & control)
  • Cardiovascular Diseases (mortality, prevention & control)
  • Female
  • Hospital Mortality (trends)
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention (adverse effects, mortality)
  • Perioperative Care (methods, mortality)
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: